Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Remy Cointreau (RCOP.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (€) Price Target (€) Rating
2022-02-28172.70198.00Neutral
2022-08-01191.70207.00Neutral
2023-01-12175.70195.00Buy
2023-05-03155.15183.00Buy
2023-06-05138.65179.00Buy
2023-11-22113.85162.00Buy
2023-12-05108.00113.00Neutral
2024-01-1095.28107.00Neutral
2024-04-2990.55100.00Neutral
2024-06-0783.7093.00Neutral
2024-10-0861.7571.00Neutral
2024-10-2859.9565.00Neutral
2024-12-0259.3564.00Neutral
2025-01-0758.0562.00Neutral
2025-01-3056.0060.00Neutral
2025-04-0843.4046.00Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.